KRBPQKiromic BioPharma, Inc.

About Kiromic BioPharma, Inc. (KRBPQ)

Kiromic BioPharma, Inc. (KRBPQ) is a Biotechnology company headquartered in Houston, TX, United States whose shares trade over-the-counter on the Pink tier.

Kiromic BioPharma, Inc. is a clinical stage, fully integrated biotherapeutics company formed under the Texas Business Organizations Code in December 2012. The Company is an allogeneic Gamma Delta T-cell therapy company featuring unique, proprietary end-to-end bioinformatic, AI targeting, and manufacturing technologies to address solid tumors. Our end-to-end approach consists of target discovery and validation, product development, and on-site current good manufacturing practices ("cGMP"), which we believe will allow us to leverage a new framework for the next generation of cell therapies.

Products and services

Kiromic Biopharma manufactures off-the-shelf cell therapies. The company currently has 3 product candidates: Deltacel, Isocel, and Procel. They are based on donor-derived peripheral blood mononuclear cells obtained from leukapheresis products. From this raw material, Kiromic manufactures clinical-grade, cryopreserved gamma/delta T cells with multiple indications. Kiromic has one product in Phase 1 stage of clinical trials, Deltacel, indicated for stage 4 non small cell lung cancer. In 2025, the company plans to enter clinical testing of Isocel for pancreatic cancer and malignant pleural mesothelioma, and of Procel for gastrointestinal cancers.

KRBPQ key facts

Ticker symbol

KRBPQ

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Houston, TX, United States

Country of incorporation

US

Year of incorporation

2015

Employees

35

Estimated market cap

$130.3K (as of Apr 15, 2025)

Shares outstanding

1,570,919

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Kiromic BioPharma, Inc. leadership

• Pietro Bersani — CEO
• Timothy Simkiss — Controller
• Accounts Payable — Other
• Trish Faulkner — Other

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with K